Andere talen TransMedics Group, Inc.

Aandelen

TMDX

US89377M1099

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
89,25 ^USD	+0,42%		+2,30%	+13,07%

18/04	Transmedics Group Insider verkocht aandelen ter waarde van $380.480, volgens een recente SEC filing	MT
05/04	Transmedics Group Insider verkocht aandelen ter waarde van $802.084, volgens een recente SEC filing	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Transmedics Group Insider Sold Shares Worth $380,480, According to a Recent SEC Filing	18/04
TransMedics to Report First Quarter 2024 Financial Results on April 30, 2024	16/04
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	08/04
Transmedics Group Insider Sold Shares Worth $802,084, According to a Recent SEC Filing	05/04
Transmedics Group Insider Sold Shares Worth $1,110,150, According to a Recent SEC Filing	02/04
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	19/03
TMDX INVESTOR NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation - TMDX	03/03
TransMedics to Present at Upcoming March Investor Conferences	28/02
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	28/02
Top Premarket Gainers	27/02
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation – TMDX	27/02
TransMedics: Q4 Earnings Snapshot	26/02
TransMedics Group Swings to Net Income in Q4, Revenue Increases; Sets 2024 Revenue Outlook-- Shares Rise	26/02
TransMedics Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26/02
TransMedics Group, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	26/02
TransMedics Reports Fourth Quarter and Full Year 2023 Financial Results	26/02
Earnings Flash (TMDX) TRANSMEDICS GROUP Posts Q4 Revenue $81.2M, vs. Street Est of $68.5M	26/02
Transmedics Group, Inc. Provides Revenue Guidance for the Full-Year 2024	26/02
Transmedics Group Insider Sold Shares Worth $279,720, According to a Recent SEC Filing	21/02
Transmedics Group Insider Sold Shares Worth $344,432, According to a Recent SEC Filing	16/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen TransMedics Group, Inc.

Aandelen

TMDX

US89377M1099

Andere talen

Filters